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A large number of studies have shown a potential association between periodontal and
autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythemato-
sus  (SLE). Similar mechanisms of tissue destruction concerning periodontitis and other
autoimmune diseases have stimulated the study of a possible relationship between these
conditions. This study aims to review the literature about this potential association and
their different pathogenic mechanisms. Considering that periodontal disease is a disease
characterized by inﬂammation inﬂuenced by infectious factors, such as SLE, it is plausible to
suggest that SLE would inﬂuence periodontal disease and vice versa. However, this issue is
not  yet fully elucidated and several mechanisms have been proposed to explain this associ-
ation, as deregulation mainly in innate immune system, with action of phagocytic cells and
proinﬂammatory cytokines such as IL-1 and IL-18 in both conditions’ pathogenesis, leading
to  tissue destruction. However, studies assessing the relationship between these diseases
are  scarce, and more studies focused on common immunological mechanisms should be
conducted to further understanding.
© 2015 Elsevier Editora Ltda. All rights reserved.
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Um grande número de estudos tem mostrado uma potencial associac¸ão entre doenc¸as peri-
odontais e doenc¸as autoimunes, como artrite reumatoide e lúpus eritematoso sistêmico
(LES).  Os mecanismos de destruic¸ão tecidual semelhantes entre a periodontite e as demais
doenc¸as  autoimunes têm estimulado o estudo de possíveis relac¸ões entre essas condic¸ões.
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heumatology, Núcleo de Estudos da Saúde do Adolescente (NESA), Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ,
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O presente estudo tem como objetivo revisar a literatura acerca dessa potencial associac¸ão e
dos  seus diferentes mecanismos patogênicos. Considerando-se a doenc¸a periodontal uma
doenc¸a  de caráter inﬂamatório que sofre inﬂuência de fatores infecciosos, assim como o
LES,  é plausível sugerir que o LES inﬂuenciaria sua progressão, assim como a periodontite
inﬂuenciaria a progressão do LES. Entretanto, essa questão ainda não é totalmente elucidada
e  vários mecanismos têm sido propostos para explicar tal associac¸ão, como desregulac¸ões,
principalmente no sistema imune inato, com ac¸ões de células fagocíticas e de citocinas pró-
inﬂamatórias, como IL-1 e IL-18, na patogênese de ambas as condic¸ões, o que contribui para
a  destruic¸ão tecidual. Existem, contudo, poucos estudos na literatura que avaliam a relac¸ão
entre  essas doenc¸as e mais trabalhos focados nos mecanismos imunológicos comuns a
ambas as condic¸ões devem ser feitos para um maior entendimento.
© 2015 Elsevier Editora Ltda. Todos os direitos reservados.Introduction
Periodontitis is a chronic destructive inﬂammation that leads
to the loss of supporting tissues of teeth and eventually even
to tooth loss. The periodontal ligament and bone tissue are
destroyed by an immune and inﬂammatory response to the
presence of bacteria, particularly gram-negative ones, in the
gingival sulcus. The severity of inﬂammation varies between
individuals, irrespective of the degree of bacterial infection,
suggesting that a dysregulation of the host inﬂammatory
response may contribute to its existence.1
On the other hand, systemic lupus erythematosus (SLE) is
an autoimmune disease of unknown origin, which affects the
connective tissue and thus various organs in the body. The
clinical manifestations of SLE vary with the severity of the dis-
ease, and its course may exhibit periods of exacerbation and
remission.2 SLE is characterized by immune responses against
a large number of autoantigens, affecting more  often women
in the second and third decades of life.3
A large number of studies have shown a potential associa-
tion between chronic periodontitis and autoimmune disease,
especially rheumatoid arthritis,4 as well as inﬂammatory
bowel disease and glomerulonephritis.5 A high prevalence
of periodontitis has also been detected in patients with
SLE.6,7
The similar mechanisms of tissue destruction for peri-
odontitis and other autoimmune diseases have stimulated
the study of potential associations between these conditions.
In spite of presenting different etiologies, the existence of
similar destructive mechanisms could explain an eventual
association between periodontitis and SLE.8 These potential
mechanisms in common may involve deregulation, especially
in the innate immune system, with action of phagocyte cells
and of proinﬂammatory cytokines, such as IL-1 and IL-18,
in the pathogenesis of both conditions, contributing to tissue
destruction.6,9
The literature describing oral conditions of patients with
lupus is scarce, and pertinent information is conﬂicting.
Considering the possibility of SLE as a modifying condition of
the periodontal health-disease process and the lack of infor-
mation to clarify this interrelationship, our aim is to review
the literature on SLE and a potential relationship with peri-
odontal disease. Despite its high prevalence in rheumatoid
arthritis, only a limited number of studies have examinedoral conditions, in particular periodontal disease in SLE
patients.10,11
Literature  review  and  discussion
Deﬁnition
Periodontal disease is deﬁned as any hereditary or acquired
disorder of tooth surrounding and supporting tissues
(periodontium). Periodontal disease has neoplastic, develop-
mental, inﬂammatory, traumatic, metabolic or genetic origin.
However, the term periodontal disease generally refers to
those common inﬂammatory disorders of gingivitis and peri-
odontitis, which are caused by pathogenic microorganisms in
a bioﬁlm or plaque that forms adjacent to the teeth. Gingivitis,
the mildest form of periodontal disease, is highly prevalent
and readily reversible with an effective oral hygiene. On the
other hand, the inﬂammation that extends deep into tissues
and causes loss of supporting connective tissue and alveolar
bone is known as periodontitis. It results in the formation of a
soft tissue pocket between the gum and root of the teeth and
can result in tooth loss.12
On the other hand, systemic lupus erythematosus is an
autoimmune disease that affects the connective tissue and
may extend to various organs of the body. The clinical man-
ifestations vary greatly between organs and systems and the
course of the disease goes through periods of exacerbation and
remission.2,10
Etiology
Periodontitis has its onset and is perpetuated by a group of
bacteria, predominantly gram-negative and anaerobes, that
colonize the subgingival area. Today, it is already clear that
these bacteria cause indirect tissue destruction, activating var-
ious mechanisms of host immunity.13
It is believed that in SLE, a disease of unknown origin,
there is an accumulation of disorders. Potential complications
may be associated with hormonal imbalances, viral infections,
impaired function of suppressor T cells, defective genetic con-
trol of immune responses, abnormal function of macrophages,
B cell intrinsic defects, poor host response to an infectious
agent, or a combination of such elements.14
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mmune  changes
n periodontal disease, host response has been tradition-
lly mediated by T and B lymphocytes, neutrophils and
onocytes/macrophages. These cells are triggered to produce
nﬂammatory mediators, including cytokines, chemokines,
rachidonic acid metabolites and proteolytic enzymes, which
ollectively contribute to the degradation of tissue and bone
esorption by activation of multiple degradation pathways.15
Immunological changes in SLE include B lympho-
yte hyperactivity and result in increased synthesis of
mmunoglobulins and antibodies, also resulting in deposition
f immune complexes and subsequent damage to connec-
ive tissue and to multiple organs. The interaction among
ypereactive B cells, abnormally activated T cells and antigen
resenting cells leads to the production of various inﬂam-
atory cytokines, apoptosis, autoantibodies and immune
omplexes which, in turn, activate effector cells and the
omplement system, leading to tissue injury and to damage
hat are the hallmark of clinical manifestations of SLE.
Periodontitis, although an infectious disease, exhibits very
imilar characteristics to SLE pathophysiology. A large number
f B lymphocytes and plasma cells have also been detected
n periodontal lesions.16 Previous studies have demonstrated
peciﬁc IgG responses against periodontopathogenic bacteria
n inﬂamed gingival tissue and crevicular ﬂuid.17,18
In periodontitis, tissue damage also derives from an exces-
ive and unregulated production of various inﬂammatory
ediators and destructive enzymes, in response to the pres-
nce of the bacterial bioﬁlm.
enetic  and  familial  factors
n periodontal disease, hosts respond differently to bacte-
ial invasion, and the quantity and quality of the bioﬁlm
annot explain the different responses.19 Only 20% of the
ariability in the expression of periodontal diseases seems
o be explained by the presence of pathogenic bacteria.20
ecently, studies have suggested that a signiﬁcant part of this
esponse variation is the result of genetic predisposition.21,22
ther risk factors, such as smoking and diabetes, are already
ell established.23 Polymorphisms of interleukin-1 gene were
escribed as the ﬁrst genetic markers related to chronic
eriodontitis.24 Since then, a number of other polymor-
hisms have been studied. Trevillato et al.,25 for instance,
ave demonstrated that IL-6 polymorphism is associated with
usceptibility to chronic periodontitis in Brazilian Caucasian
atients.
Genetic and gene expression studies in patients with SLE
ave also revealed new genetic mutations and alterations
n cytokines that can explain several features of the dis-
ase, as well as its genetic susceptibility. The Fc  receptor (an
mmunoglobulin G receptor) gene family is one of the most
tudied, and has an important role in the regulation of host
mmune response to bacterial challenge.26 Polymorphisms
n this receptor are related to some autoimmune diseases,
ncluding SLE and juvenile idiopathic arthritis (JIA). There are
ome studies linking polymorphisms in this receptor also with
eriodontitis. Kobayashi et al.7 found an increased frequency
f FcRIIa-R131 alleles in SLE and periodontitis patients, 6;5 6(2):165–170 167
compared to healthy patients without periodontitis. In this
study, the authors concluded that patients with SLE presenting
polymorphism in FcRIIa gene have a higher risk of developing
periodontitis. This polymorphism is associated with a ligand
deﬁciency with IgG2, which is common in periodontitis and
SLE.
Cytokines  as  biomarkers
Several studies point to cytokines as important medi-
ators associated with the pathogenesis of periodontitis.
Bacterial products induce synthesis of proinﬂammatory
cytokines such as interleukin-1 beta (IL-1), interleukin-6 (IL-
6), Interleukin-8 (IL-8) and tumor necrosis factor (TNF), mainly
by macrophages.27
Among various cytokines, TNF and IL-1, mediators that
can potentially participate in this process, stand out. These
cytokines stimulate bone resorption by directly inducing the
proliferation of osteoclast progenitors, and indirectly by stim-
ulating the resorptive activity of mature osteoclasts28 and
increasing collagenase synthesis.29
In SLE, IL-6, as well as IL-10, TNF, IL-17 and IL-18, levels have
been correlated with disease activity; and a predominance
of Th2 response has been reported.30 The balance among
cytokines and their receptors might also be important, not just
considering their absolute level. Higher serum levels of IL-12
and IL-18 were identiﬁed in the study by Robak et al.31 in SLE
patients versus healthy patients, and this ﬁnding could indi-
cate a pathogenetic role. However, their levels did not correlate
with disease activity and were not responsive to immunosup-
pressive treatment.
IL-18, an IL-1 family member, is expressed in various cell
types, including macrophages, T lymphocytes, B lymphocytes,
and dendritic cells. Studies have shown that IL-18 plays a
major role in the pathogenesis of various autoimmune dis-
eases, being strongly expressed both locally and systemically
in adult patients with SLE.32 Areas et al.33 showed that serum
levels of IL-18 were increased in adolescents with SLE and
that these levels correlated positively with SLEDAI index. On
the other hand, there is scarce information about the pres-
ence and role of IL-18 in the periodontium. What is known
is that gingival epithelial cells express this cytokine consti-
tutively, producing it under in vitro stimulation.34 The study
by Miranda et al.35 showed increased serum levels of IL-
18 in patients with juvenile idiopathic arthritis and found
a signiﬁcant correlation between periodontal measurements
(periodontal pocket depth and clinical attachment level) and
IL-18, indicating a possible role of this cytokine also in peri-
odontitis.
Oral  manifestations  of  SLE  and  periodontal  disease
Oral involvement is one of the diagnostic criteria for SLE (pres-
ence of oral ulcers). In the study by Rhodus and Johnson,10 the
prevalence of oral manifestations (dry mouth, dental caries,
mucositis, angular cheilitis, ulceration, among others) ranged
from 81.3 to 87.5%. All study patients exhibited xerostomia,
and 93.8% had periodontitis. On the other hand, in the study
by Khatibi et al.36 54.3% of patients had oral lesions, and
28.1% presented with ulcers. These authors emphasize that
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with a longer disease duration, the number of oral lesions
decreases. This occurs because most lesions are found in the
active period, and that with the course of the disease after
diagnosis, the control and treatment lead to a greater stabil-
ity of the disease, progressing to an inactive phase and thus
tending to a smaller number of oral lesions.
Several studies implying a potential association between
periodontitis and rheumatoid arthritis (RA) were published,4,5
and suggested a higher relative risk of periodontitis in these
patients.5 On the other hand, studies evaluating periodon-
tal involvement in SLE patients are scarce. There are some
case reports, as a case of acute necrotizing ulcerative gin-
givitis (ANUG) in a patient with SLE,37 periodontitis38 and
gingivitis.39 In the study by Mutlu et al.,11 the authors did not
ﬁnd evidence for a greater predisposition to periodontal dis-
ease in SLE patients versus healthy controls. They identiﬁed
shallower pockets in patients with SLE, a ﬁnding paralleled
by Figueredo et al.,40 and this result could be related to the
use of anti-inﬂammatory agents. On the other hand, other
authors found greater presence of periodontal disease in
SLE patients than in healthy controls.6,41,42 In the study by
Fabbri et al.,1 these authors observed for the ﬁrst time reduc-
tion of SLE activity with the use of SLEDAI index, in parallel
with a drop of periodontal indexes after periodontal treat-
ment. Importantly, in this study the control group, which
also received treatment with immunosuppressive drugs for
SLE, showed no signiﬁcant drop in SLEDAI, demonstrating a
direct association between periodontal treatment and index
improvement. Improvement in periodontal status and sys-
temic disease activity was also evident in similar studies on
patients with rheumatoid arthritis.43,44
Biological  plausibility
Periodontitis can be a critical factor in maintaining the inﬂam-
matory response that occurs in SLE. In fact, infection has been
regarded as a triggering factor for autoimmune diseases45 and
in SLE, and this condition has been responsible for the main-
tenance of disease activity. Several mechanisms have been
proposed to explain this connection, for example, an adjuvant
effect of products of microorganisms.45 In the study by Rose,46
the injection of thyroglobulin and mycobacterium products
induced the production of speciﬁc autoantibodies, as well as
inﬂammatory thyroid lesions. In addition, infectious agents
can interact with the immune system in several ways, for
instance, molecular mimicry, a change in apoptosis of host
cells and exposure of camouﬂaged antigens to the immune
system by certain microorganisms. All of these mechanisms
may give rise to dysfunctions of the immune system.47
Another potential mechanism is the presence of changes in
endothelial cells. C-reactive protein contributes to hypercoag-
ulation and increases the expression of adhesion molecules in
these cells. Its levels are elevated in patients with periodontal
disease, and autoantibodies directed against this protein are
also increased in SLE patients, suggesting a possible binding
route between these two conditions, in addition to being a risk
48factor for developing cardiovascular diseases. Moreover, as
already mentioned, polymorphism in Fc  receptor have been
associated with periodontitis and autoimmune diseases, such
as rheumatoid arthritis and SLE.7,26 0 1 6;5 6(2):165–170
Inﬂammatory cytokines also appear to play an important
role in this interrelationship. They are often involved in the
vascular process (vascular occlusion and perivascular inﬁl-
trates) in patients with SLE.49 Furthermore, changes in local
levels of several pro-inﬂammatory cytokines such as IL-1, IL-
6 and TNF- have been associated with a possible role in the
process of periodontal disease.50 Elastase, an enzyme of the
protease class, also appears to be involved in the associa-
tion between periodontal disease and SLE. Figueredo et al.40
found greater activity of this enzyme in the gingival crevicular
ﬂuid of inﬂamed sites of SLE patients, even in the presence of
lower levels of IL-18 and IL-1. This greater activity suggests
neutrophil hyperactivity in SLE, possibly generated by a pri-
mary effect caused by increased IL-18 plasma levels in these
patients.
The exact pathogenesis of SLE, as well as periodontitis, is
still unknown. According to Marks and Tullus,51 SLE in chil-
dren and adults occurs in genetically susceptible individuals,
in whom the inﬂammatory system is triggered due to a sec-
ondary stimulus (such as an environmental stimulus, p.ex.
infection), resulting in an abnormal cytokine environment.
This change in cytokines is also found in periodontitis, as
reported by Figueredo et al.52 and Rescala et al.53
Cytokines play an important role in the pathogenesis of
periodontitis. Today, many  articles in this area were published,
being of particular interest their use as biomarkers of disease
activity. Measurements of these cytokines could serve as an
alternative to help in identifying outbreak periods and for ther-
apy response monitoring. In periodontics, measures such as
pocket depth and clinical attachment level are used; but these
variables do not measure the activity of periodontal disease,
only its sequels. The current goals are to identify a cytokine or
a combination of cytokines to provide such information.
Inﬂuence  of  medications
Regarding the association between SLE and periodontal dis-
eases, the divergence observed between studies may be
explained in part by the inﬂuence of medication. The con-
tinued use of drugs might mask or mitigate the severity of
periodontal disease. The use of different drugs and in differ-
ent dosage complicates the analysis of these patients, since
they exhibit different clinical manifestations and, therefore,
different treatments. The controversy is whether the observed
improvement in patients is a result of periodontal treatment
itself, or of the use of immunosuppressive medication. It is
known that the use of corticosteroids may exhibit antagonistic
functions, since this drug predisposes to infection and, at the
same time, may mask clinical characteristics of the infection
as a result of its immunosuppressive and anti-inﬂammatory
effects.2
Also, it is important to evaluate other factors, such as
socio-demographic data, disease duration, clinical activity,
laboratory tests, among others, to homogenize as much as
possible the study groups, thus allowing an evaluation of
the inﬂuence of periodontal treatment on disease course,
without the inﬂuence of other factors. These precautions
were not observed in some studies such as Mutlu et al.’s11
and Kobayashi et al.’s.7 On the other hand, in the study by
Fabbri et al.,1 there was a concern to evaluate the regime
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f medications used, duration of disease and inﬂammatory
arkers among patients.
Children and adolescents under treatment with immuno-
uppressive drugs are at a higher risk of developing
ystemic complications from oral infections.54 The damping
f periodontal infection progression, thanks to periodontal
reatment, would decrease the levels of inﬂammatory markers
uch as IL-6, TNF- and C-reactive protein, which are common
o SLE and periodontitis, and this would contribute to decrease
he systemic inﬂammation in these patients.48
onclusion
onsidering periodontal disease as a condition characterized
y inﬂammation and inﬂuenced by infectious factors, such
s SLE, it is reasonable to suggest that SLE would inﬂuence
he progression of periodontal disease, and vice versa. Stud-
es evaluating the relationship between SLE and periodontitis
re scarce. More  studies focused on the immunological mech-
nisms common to both conditions must be conducted, to
btain a better understanding. The hypothesis of a possible
ink between SLE and periodontitis and between SLE activ-
ty and periodontal destruction need to be investigated by
ongitudinal studies, for a better understanding of possible
ommon pathogenic processes.
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